Search | Page 4 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. UCB Transplant for Hematological Diseases Using a Non Myeloablative Prep

    ... myelodysplastic syndromes (MDS) Associated Drug(s):  ... risk cytogenetics based on IPSS or R-IPSS definitions; therapy-related MDS . Blasts must be < 5% by a representative bone ...

    Clinical Trial last updated 04/29/2016 - 10:06am.

  2. Allo HSCT Using RIC for Hematological Diseases

    ... myelodysplastic syndromes (MDS) Phase:  ... risk cytogenetics based on IPSS or R-IPSS definitions; therapy-related MDS . Blasts must be < 5% by bone marrow aspirate ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  3. MDS: Causes

    What causes MDS? Most experts agree that MDS should be considered a cancer of the ... as a result of therapies for other cancers – what we call therapy-related MDS, or t-MDS. This is the type of MDS that occurred in Robin ...

    Page last updated 02/25/2015 - 11:31am.

  4. Stem Cell Transplants May Be An Option for Some Elderly MDS Patients

    ... Myelodysplastic Syndromes (MDS) is considered a disease of the hematopoietic (blood-forming) stem ... conditioning regimen was indeed associated with a lower therapy-related mortality, however, it was also associated with an higher risk ...

    Research Review last updated 05/02/2016 - 9:33am.

  5. Myeloablative Unrelated Donor Cord Blood Transplantation With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cells for Patients With High Risk Hematological Malignancies

    ... myelodysplastic syndromes (MDS) Phase:  ... years Diagnosis Any acute leukemia in CR1 - CR2 (includes therapy-related and arising from MDS or myeloproliferative disease). JMML in ...

    Clinical Trial last updated 04/29/2016 - 1:33pm.